Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Unlocking Insights: A Single Centre Patient-Reported Outcome Experience in Patients with Severe Hemophilia a without Inhibitors on Emicizumab

Ingrid Blydt-Hansen, Michelle Bech, Zainab Al-Housni, Federico Germini, Mark W Skinner, Shannon Jackson

Blood (2023) 142 (Supplement 1): 7328.

https://doi.org/10.1182/blood-2023-188221

Published: 2023

Journal Articles

The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease

Michelle Sholzberg, Grace H Tang, Paula D. James, Filomena Meffe, Emily Rimmer, Shannon Jackson, Haowei Linda Sun, Sue Robinson, Georgina Floros, Shamshah Aratia, Peter Jüni, Bruno R. da Costa

Blood (2022) 140 (Supplement 1): 8483–8484.

https://doi.org/10.1182/blood-2022-168675

Published: 2022

Journal Articles

Risk of Hypertension in Hemophilia Patients with a History of Inhibitors

Anna Ter-Zakarian, Richard Barnes, PhD MPH, Rebecca Kruse-Jarres, MD MPH, Doris Quon, MD PhD, Shannon Jackson, MD FRCPC, Linda Sun, MD, Annette von Drygalski, MD PharmD, RMSK

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136133

Published: 2020

Journal Articles

The Use of Chromogenic Factor VIII Assay Changes Treatment Approach in a Portion of Mild Hemophilia A Patients with Factor VIII Assay Discrepancy

Muntadhar Al Moosawi, MD, Karen L. Dallas, MD FRCPC, Steven Wong, Shannon Jackson, MD FRCPC

Blood (2019) 134 (Supplement_1): 906.

https://doi.org/10.1182/blood-2019-123799

Published: 2019

Journal Articles

A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a

Victor S. Blanchette, FRCP, Laura Tiseo, BSc, CCRP, David Lillicrap, MD, Shannon Jackson, MD FRCPC, Massimo Morfini, MD, Vanessa Bouskill, MN, Manuel Carcao, Margaret L. Rand, PhD, Derek Stephens, MSc, Liane Khoo, MD, Ester Zapotocka, MD, Vladimir Komrska, MD, Jan Blatny, MD PhD

Blood (2018) 132 (Supplement 1): 2480.

https://doi.org/10.1182/blood-2018-99-111024

Published: 2018

Journal Articles

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Haowei Linda Sun, MD FRCPC, Ming Yang, PhD, Man-Chiu Poon, MD, Adrienne Lee, MD, Katherine Sue Robinson, MD, Michelle Sholzberg, MDM, MSc, FRCPC, John K. Wu, MBBS, FRCPC, MS, Alfonso Iorio, MD PhD, Victor S. Blanchette, FRCP, Robert J Klaassen, MD FRCPC, Shannon Jackson, MD FRCPC

Blood (2018) 132 (Supplement 1): 4813.

https://doi.org/10.1182/blood-2018-99-113858

Published: 2018

Journal Articles

Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a

Barbara Konkle, MD, K John Pasi, David J Perry, Johnny Mahlangu, Savita Rangarajan, Simon A Brown, Hideji Hanabusa, Ingrid Pabinger, Lynda M Cristiano, Elisa Tsao, Bent Winding, Desilu Glazebrook, Stefan Lethagen, Shannon Jackson

Blood (2016) 128 (22): 1413.

https://doi.org/10.1182/blood.V128.22.1413.1413

Published: 2016

Journal Articles

Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A-LONG and ASPIRE

K John Pasi, David J Perry, Johnny Mahlangu, Barbara A Konkle, MD, Savita Rangarajan, Simon Brown, Hideji Hanabusa, Shannon Jackson, Ingrid Pabinger, Lynda M Cristiano, Yingwen Dong, Elisa Tsao, Glenn F Pierce, Geoffrey Allen

Blood (2015) 126 (23): 1087.

https://doi.org/10.1182/blood.V126.23.1087.1087

Published: 2015

Journal Articles

Hematuria Is Not a Risk Factor for the Hypertension of Hemophilia

Haowei (Linda) Sun, MD, Ming Yang, PhD, Afrah S Sait, MD, Annette Von Drygalski, MD PharmD, Shannon Jackson

Blood (2015) 126 (23): 2301.

https://doi.org/10.1182/blood.V126.23.2301.2301

Published: 2015

Journal Articles

High False Positive Rate Of An ELISA Screen For The Detection Of Anti-Factor VIII Antibodies In Congenital Hemophilia A

Jaime Kwok, Ming Yang, John K. Wu, MBBS, FRCPC, Cedric J. Carter, MD, FRCPC, Shannon Jackson, MD, FRCPC

Blood (2013) 122 (21): 3586.

https://doi.org/10.1182/blood.V122.21.3586.3586

Published: 2013

Journal Articles

An Increase in Factor VIII Levels with Increasing Age in a Subgroup of Individuals with Mild Hemophilia A

Lauren J Lee, John K. Wu, MBBS, FRCPC, Man-Chiu Poon, MD, Shannon Jackson, MD, FRCPC

Blood (2011) 118 (21): 2278.

https://doi.org/10.1182/blood.V118.21.2278.2278

Published: 2011

Journal Articles

Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease

Musa Alzahrani, MD, Mark C Hull, MD, Christopher Sherlock, MD, Deborah Griswold, MD, Chantal S Leger, MD, Shannon Jackson, MD, Christopher P Venner, BSc, MD, Tyler W Smith, MD, Heather A Leitch, MD, PhD

Blood (2010) 116 (21): 3897.

https://doi.org/10.1182/blood.V116.21.3897.3897

Published: 2010

Journal Articles

Prevalence of Suspected Collagen Disorders In the Adult Bleeding Disorder Clinic.

Shannon Jackson, MD, FRCPC, Leah Odiaman, RN, Morna Brown, RN, Carol Spitzer, RN, Robert T. Card, MD, FRCPC, Man-Chiu Poon, MD

Blood (2010) 116 (21): 1399.

https://doi.org/10.1182/blood.V116.21.1399.1399

Published: 2010

NARROW

Unlocking Insights: A Single Centre Patient-Reported Outcome Experience in Patients with Severe Hemophilia a without Inhibitors on Emicizumab

The Empower Study - Design of a Randomized Clinical Trial to Assess the Efficacy and Safety of a Plasma-Derived Von Willebrand Factor / Factor VIII Concentrate for Heavy Menstrual Bleeding in Women with Von Willebrand Disease

Risk of Hypertension in Hemophilia Patients with a History of Inhibitors

The Use of Chromogenic Factor VIII Assay Changes Treatment Approach in a Portion of Mild Hemophilia A Patients with Factor VIII Assay Discrepancy

A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a

Observational Study of Real-World Factor Utilization and Health Outcomes in Patients with Hemophilia in Canada

Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIFc) in Adults/Adolescents with Severe Hemophilia a

Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A-LONG and ASPIRE

Hematuria Is Not a Risk Factor for the Hypertension of Hemophilia

High False Positive Rate Of An ELISA Screen For The Detection Of Anti-Factor VIII Antibodies In Congenital Hemophilia A

An Increase in Factor VIII Levels with Increasing Age in a Subgroup of Individuals with Mild Hemophilia A

Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease

Prevalence of Suspected Collagen Disorders In the Adult Bleeding Disorder Clinic.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only